Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,014 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: maguire m. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
Epilepsy.
Marson AG, Maguire M, Ramaratnam S. Marson AG, et al. Among authors: maguire m. BMJ Clin Evid. 2009 Jan 28;2009:1201. BMJ Clin Evid. 2009. PMID: 19445769 Review.
Epilepsy (generalised).
Maguire M, Marson AG, Ramaratnam S. Maguire M, et al. BMJ Clin Evid. 2010 Jun 22;2010:1201. BMJ Clin Evid. 2010. PMID: 21418687 Free PMC article. Review.
Epilepsy (partial).
Maguire M, Marson AG, Ramaratnam S. Maguire M, et al. BMJ Clin Evid. 2010 Jun 28;2010:1214. BMJ Clin Evid. 2010. PMID: 21429248 Review.
Epilepsy (partial).
Maguire M, Marson AG, Ramaratnam S. Maguire M, et al. BMJ Clin Evid. 2011 May 6;2011:1214. BMJ Clin Evid. 2011. PMID: 21549021 Free PMC article. Review.
Epilepsy (generalised).
Maguire M, Marson AG, Ramaratnam S. Maguire M, et al. BMJ Clin Evid. 2012 Feb 20;2012:1201. BMJ Clin Evid. 2012. PMID: 22348419 Free PMC article. Review.
Epilepsy and psychosis: a practical approach.
Maguire M, Singh J, Marson A. Maguire M, et al. Pract Neurol. 2018 Apr;18(2):106-114. doi: 10.1136/practneurol-2017-001775. Epub 2017 Dec 22. Pract Neurol. 2018. PMID: 29273616 Review.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: maguire m. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Marson AG, et al. Among authors: maguire m. Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Free article. Clinical Trial.
1,014 results